Search results with tag "Carboplatin"
Thames Valley SACT Regimens
thamesvalleycanceralliance.nhs.ukCarboplatin AUC7 Dysgerminoma and seminoma 29 Methotrexate 50 Germ cell 30 Methotrexate weekly Germ cell 31 Bevacizumab 7.5mg/kg Ovarian, fallopian, peritoneal 32 Carboplatin desensitisation 34 Niraparib Ovarian, fallopian tube, peritoneal 36 Paclitaxel carboplatin 21 day Ovarian + endometrial + cervical 39
UP Health System Marquette Pharmacy and Therapeutics ...
www.mgh.orgDrug Names Drugs as They Would Appear on MAR Potential Errors and Consequences Safety Strategies 1. Cisplatin and Carboplatin Platinol (CISplatin) Paraplatin (CARBOplatin) Doses appropriate for carboplatin usually exceed the maximum safe dose of cisplatin. Severe toxicity and death has been associated with accidental cisplatin overdoses.
DRUG NAME: Oxaliplatin - BC Cancer
www.bccancer.bc.caDRUG NAME: Oxaliplatin ... and carboplatin. 1. The exact mechanism of action of oxaliplatin is not known. Oxaliplatin forms reactive platinum complexes which are believed to inhibit DNA synthesis by forming interstrand and intrastrand cross-linking of DNA molecules. Oxaliplatin is not generally cross-resistant to cisplatin or carboplatin,
DRUG NAME: Carboplatin - BC Cancer
www.bccancer.bc.caCarboplatin Myelosuppression is the dose-limiting toxicity, usually manifested as thrombocytopenia and less commonly as leukopenia, neutropenia and anemia. Risk factors include prior cytotoxic therapy (especially cisplatin), poor performance status, old age, impaired renal function and concurrent myelosuppressive therapy.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu3 Bevacizumab, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum -sensitive
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eupaclitaxel and carboplatin, is indicated only after failure of appropriate targeted therapies (see section 5.1). Tecentriq, in combination with nab - paclitaxel and carboplatin, is indicated for the first -line treatment of adult patients with metastatic non- squamous NSCLC who do not have EGFR mutant or
Avastin® (Bevacizumab) – Medicare Advantage Policy Guideline
www.uhcprovider.comThe drug must be used according to the indication and protocol listed in the accepted compendia ... o First-line treatment in combination with paclitaxel and carboplatin for unresectable, locally advanced, recurrent or ... complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-
Prescription Drug Listing - horizonnjhealth.com
www.horizonnjhealth.comCARBILEV carboplatin CARDEC CARDEC DM carisoprodol* CARMOL 40 CARMOL SCALP CARMOL-HC cartia xt CATAPRES-TTS* carvedilol* CAYSTON* cefaclor, ER
Protocol: Carboplatin/Gemcitabine - Mid-Western Cancer …
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 2 Protocol: Cisplatin/Gemcitabine Indications: Lung Cancer (non-small cell) – Adjuvant, Neoadjuvant
Germ Cell regimens Approved v4.02 NWLCN 29Oct13
www.londoncanceralliance.nhs.ukGerm Cell regimens Approved v4.02 NWLCN 29Oct13.doc Urology GCT page 6 of 22 4. CEB (CTIS: 1124) Etoposide 120mg/m2 IV over 1 hour Days 1,2 and 3 Carboplatin …
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzAvastin (bevacizumab) in combination with carboplatin and paclitaxel is indicated for the treatment of patients with recurrent, platinum-sensitive, epithelial ovarian, fallopian tube, or
Chemotherapy Sequencing Guide – For therapies given on …
sites.mckesson.comBevacizumab Bleomycin Carboplatin Cisplatin Cyclophosphamide Cytarabine Dacarbazine Docetaxel Doxorubicin Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine ...
For Health Professionals Who Care For Cancer Patients
www.bccancer.bc.caCarboplatin and Paclitaxel with Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LULACATRT) – A new chemoradiation regimen for patients with locally advanced non-small cell lung cancer (NSCLC) is now available. It is an alternative to the existing cisplatin and etoposide protocols
BC Cancer Protocol Summary for Primary Treatment of No ...
www.bccancer.bc.cab) at nadir (until nadir pattern established): ANC (x 109/L) Platelets (x 109/L) PACLItaxel CARBOplatin* greater than or equal to 1.5 and greater than or equal to 100 100% 120%** 0.5-1.4 and greater than or equal to 75 100% 100%
Protocol: Carboplatin/Paclitaxel - Mid-Western Cancer Centre
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 60 Protocol: PMB (Cisplatin/Methotrexate/Bleomycin) Indications: Cervix Cancer – Advanced, Recurrent
Extravasation/Infiltration Management Chart
pedsrx.johnshopkins.eduCARBOplatin X € With or without pain Carmustine X € Cool to touch CISplatin* X X € Edema <1" in any direction Cladribine X X € Skin blanched Cyclophosphamide X X € With or without pain Cytarabine X X € Cool to touch Dacarbazine X € Edema 1-6" in any direction Dactinomycin* X € Skin blanched, translucent DAUNorubicin* X X €
NCCN Clinical Practice Guidelines in Oncology NCCN ...
www2.tri-kobe.orgCarboplatin + albumin-bound paclitaxel + atezolizumab as an "other recommended" treatment option as a category 2A. Nivolumab + ipilimumab as an "other recommended" treatment option as a category 2A. NSCL-J 3 of 4 • The following treatment options added for patients with metastatic squamous cell NSCLC, PD-L1 <1%, and PS 0-1.
CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION …
www.mhra.gov.ukMHRA-UKPAR – Carboplatin 10 mg/ml Concentrate for Solution for Infusion PL 08137/0150-2 -5 - PHARMACEUTICAL ASSESSMENT DRUG SUBSTANCE Carboplatin
Carboplatin / Etoposide (IV D1; PO D2,D3) in Metastatic or ...
www.londoncanceralliance.nhs.ukFebrile neutropenia is diagnosed, Consider Etoposide 75% dose and Carboplatin 100% dose . Renal Impairment: Carboplatin: Contraindicated if CrCl < 20ml/min
Similar queries
Carboplatin, Drug, DRUG NAME, DRUG NAME: Carboplatin, Neutropenia, Paclitaxel, Name, Protocol: Carboplatin/Gemcitabine, NEW ZEALAND DATA SHEET, Chemotherapy Sequencing Guide – For therapies, Bevacizumab, Gemcitabine, For Health Professionals Who Care For Cancer, Protocol, PACLItaxel CARBOplatin, Protocol: Carboplatin/Paclitaxel, CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION, Carboplatin 10 mg/ml Concentrate for Solution for Infusion, Carboplatin / Etoposide IV D1; PO, Etoposide